TUMMINELLO, Francesca Maria
 Distribuzione geografica
Continente #
NA - Nord America 4.189
EU - Europa 1.943
AS - Asia 1.600
SA - Sud America 264
Continente sconosciuto - Info sul continente non disponibili 162
AF - Africa 38
OC - Oceania 1
Totale 8.197
Nazione #
US - Stati Uniti d'America 4.098
SG - Singapore 601
RU - Federazione Russa 513
CN - Cina 436
IT - Italia 333
FI - Finlandia 249
BR - Brasile 198
UA - Ucraina 175
DE - Germania 167
HK - Hong Kong 157
VN - Vietnam 147
PL - Polonia 121
GB - Regno Unito 104
FR - Francia 75
IE - Irlanda 72
JP - Giappone 54
SE - Svezia 50
CA - Canada 43
IN - India 38
BD - Bangladesh 30
KR - Corea 26
TR - Turchia 19
AR - Argentina 18
ES - Italia 18
MX - Messico 18
BE - Belgio 15
IQ - Iraq 14
VE - Venezuela 14
CO - Colombia 12
NL - Olanda 12
UZ - Uzbekistan 10
CI - Costa d'Avorio 8
MA - Marocco 8
NP - Nepal 8
RO - Romania 8
CR - Costa Rica 7
EC - Ecuador 7
AZ - Azerbaigian 6
CZ - Repubblica Ceca 6
MY - Malesia 6
PH - Filippine 6
ZA - Sudafrica 6
CH - Svizzera 5
CL - Cile 5
ID - Indonesia 5
IR - Iran 5
JO - Giordania 5
PK - Pakistan 5
SA - Arabia Saudita 5
AT - Austria 4
HN - Honduras 4
KZ - Kazakistan 4
LT - Lituania 4
PY - Paraguay 4
DZ - Algeria 3
JM - Giamaica 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BB - Barbados 2
BO - Bolivia 2
BS - Bahamas 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
EG - Egitto 2
ET - Etiopia 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
NI - Nicaragua 2
PT - Portogallo 2
SV - El Salvador 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AO - Angola 1
AU - Australia 1
AW - Aruba 1
BG - Bulgaria 1
BH - Bahrain 1
CG - Congo 1
DK - Danimarca 1
EU - Europa 1
GE - Georgia 1
GM - Gambi 1
GP - Guadalupe 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
IL - Israele 1
KH - Cambogia 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
MU - Mauritius 1
PA - Panama 1
SN - Senegal 1
SR - Suriname 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.036
Città #
Ashburn 478
Singapore 404
San Jose 297
Fairfield 280
Chandler 278
Dallas 240
Woodbridge 190
Ann Arbor 161
Houston 145
Hong Kong 144
Wilmington 140
Seattle 113
Cambridge 107
Jacksonville 90
Palermo 86
Zgierz 86
Moscow 84
Council Bluffs 77
Dublin 72
Beijing 71
Des Moines 65
Los Angeles 65
Medford 62
Santa Clara 55
New York 52
Frankfurt am Main 51
Ho Chi Minh City 51
Tokyo 51
Altamura 43
Princeton 43
The Dalles 39
Lauterbourg 37
Hanoi 33
Helsinki 32
Lawrence 32
Boardman 31
San Diego 31
Buffalo 26
Chicago 25
Nanjing 25
Jinan 23
São Paulo 23
Tulsa 23
Milan 21
Tianjin 18
Guangzhou 17
Shenyang 17
Atlanta 16
Hefei 16
Nanchang 16
Brussels 15
Montreal 15
Munich 15
Changsha 14
London 14
Warsaw 14
Orem 13
Chennai 11
Ludwigshafen am Rhein 11
Phoenix 11
Brooklyn 10
Denver 10
Lublin 10
Stockholm 10
Hebei 9
Kumar 9
Manchester 9
Poplar 9
Seoul 9
Abidjan 8
Charlotte 8
Izmir 8
Rome 8
Springfield 8
Tashkent 8
Turku 8
Washington 8
Zhengzhou 8
Caracas 7
Cardiff 7
Da Nang 7
Dearborn 7
Haiphong 7
Saint Petersburg 7
San Paolo di Civitate 7
Amsterdam 6
Baku 6
Columbus 6
Monza 6
Ningbo 6
Norwalk 6
Quito 6
Recife 6
Amman 5
City of London 5
Haikou 5
Hangzhou 5
Johannesburg 5
Lucca 5
Mexico City 5
Totale 5.004
Nome #
Cathepsin L in metastatic bone disease: therapeutic implications 339
Activin A circulating levels in patients with bone metastasis from breast or prostate cancer 320
Cathepsin D expression levels in nongynecological solid tumors: Clinical and therapeutic implications 307
Vitamin D in cancer chemoprevention 294
The role of histamine in doxorubicin and teniposide-induced cardiotoxicity in dog and mouse 285
Follistatin as potential therapeutic target in prostate cancer 282
Circulating cathepsin K and cystatin C in patients with cancer related bone disease: Clinical and therapeutic implications 275
Cathepsin L in normal and pathological bone reodeling 236
Effects of zoledronic acid on proteinase plasma levels in patients with bone metastases. 223
Serum follistatin in patients with prostate cancer metastatic to the bone 219
Serum interleukin-6 in patients with metastatic bone disease: correlation with cystatin C. 214
Effects of extra virgin olive oil phenols on HL60 cell lines sensitive and resistant to anthracycline 213
Activin A and matrix metalloproteinase -2 and -9 blood levels as gauges of bone metastatic spread 212
Differential expression levels of urokinase-type plasminogen activator and cathepsin D in locally advanced laryngeal squamous cell carcinoma: Clinical implications 207
Effect of extra virgin olive oli phenols on HL60 cell lines sensitive and resistant to anthracyclines 205
Effects of extra virgin olive oil phenols on HL60 cell lines sensitive and resistant to anthracyclines 202
Cathepsin D, B and L circulating levels as prognostic markers of malignant progression 200
Effects of Zoledronic Acid on Cathepsin K circulating levels in patients with bone metastasis. 196
Induction of differentiation by phenols crude extract of extravirgin olive oil on tumor cell lines sensitive and resistatnt to antitumor agents 191
Cytotoxic effects of polyphenols from waste-water of extra virgin olive oil on human HL60 and K562 cell lines. 190
Cytotoxic effects of a crude extract of extra virgin olive oil on human HL60 cell lines sensitive and resistant with MDR phenotype 190
New potential circulating markers for the therapeutic monitoring of metastatic bone disease. 182
Cathepsin D in the malignant progression of neoplastic diseases 175
Cathepsin D content in colorectal cancer 168
Effects of phenols of extra virgin olive oil on HL60 cell lines sensitive and reristant to anthracyclines 167
Cathepsin D activity levels in colorectal cancer: Correlation with cathepsin B and L and other biological and clinical parameters 164
Effects of E-64 (cysteine-proteinase inhibitor) and Pepstatin (aspartyl-proteinase inhibitor) on metastasis formation in mice with mammary and ovarian tumors 161
Acute myocardial effects of mitoxantrone in the rabbit 157
Cathepsin D: A possible biochemical marker for anthracycline cardiomyopathy 152
Antimetastatic activity of adriamycin in combinations with proteinase inhibitors in mice 150
Prognostic significance of DNA ploidy, S-phase fraction, and tissue levels of aspartic, cysteine, and serine proteases in operable gastric carcinoma 147
Lysosomal alterations in heart and liver of mice treated with doxorubicin 147
Sexual abuse and maltratment on child: protocols, cooperation strategies, daphne II - V.eR.S.O. (Violenza e reti sanitarie operative) Project- our experience 146
Cathepsin D Serum Mass Concentrations in Patients with Hepatocellular Carcinoma and/or Liver Cirrhosis 146
Zoledronic acid-induced variations in MMP-2, MMP-9 and uPA plasma concentrations in patients with metastatic bone disease 139
Effects of amsacrine (m-AMSA) a new aminoacridine antitumor drug, on the rabbit heart 139
Induction of differentiation by phenols crude extract of extavirgin olive oil on tumor cell lines sensitive and resistant to anticancer drugs 135
Flow cytometric DNA analysis and lysosomal cathepsins b and l in locally advanced laryngeal cancer. Relationship with clinicopathologic parameters and prognostic significance 129
Percorsi di integrazione e modello operativo della rete anti-violenza: esperienza del progetto Daphne 124
Stefin A and cathepsin B and L circulating serum levels in patients with malignant or non-malignant liver diseases: A preliminary report 123
Lysosomal aspartic and cysteine proteinases serum levels in patients with pancreatic cancer or pancreatitis 102
Pepstatins: Aspartic proteinase inhibitors having potential therapeutic applications 98
Tumor markers in urogynaecological tumors. 87
null 59
Totale 8.197
Categoria #
all - tutte 26.066
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.066


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022390 0 0 0 22 26 19 25 34 72 71 21 100
2022/2023678 71 133 21 83 57 125 41 49 64 3 23 8
2023/2024361 10 48 26 35 34 54 29 46 3 14 17 45
2024/2025730 9 15 34 92 25 35 59 42 51 97 98 173
2025/20263.000 234 59 345 249 288 438 407 276 196 346 66 96
2026/2027638 143 88 352 55 0 0 0 0 0 0 0 0
Totale 8.197